Mixed Hyperlipidemia clinical trials

Explore recruiting mixed hyperlipidemia clinical trials.

Recruiting mixed hyperlipidemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mixed Hyperlipidemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults with Dyslipidemia

Poland, Hungary, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Mixed Hyperlipidemia trials by city

Mixed Hyperlipidemia clinical trials

Recruiting mixed hyperlipidemia studies right now

Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

Also recruiting in Europe

A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults with Dyslipidemia

Mixed Hyperlipidemia trials by city

Other conditions